MUC16 and ovarian carcinoma: OVA1 is another panel of 5 biomarkers, including CA125, Transthyretin, Apolipoprotein A1, Transferrin, and B2-microglobulin, used to distinguish between the high and low risk of ovarian cancer for patients with pelvic masses.